Genpact Limited
G
$43.54
$1.303.07%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.85B | 4.77B | 4.66B | 4.59B | 4.52B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.85B | 4.77B | 4.66B | 4.59B | 4.52B |
| Cost of Revenue | 3.13B | 3.08B | 3.01B | 2.97B | 2.92B |
| Gross Profit | 1.72B | 1.69B | 1.65B | 1.62B | 1.60B |
| SG&A Expenses | 976.26M | 970.21M | 958.13M | 944.55M | 934.33M |
| Depreciation & Amortization | 23.87M | 26.48M | 27.43M | 28.44M | 30.14M |
| Other Operating Expenses | -262.00K | -4.12M | -4.11M | -4.18M | -4.20M |
| Total Operating Expenses | 4.13B | 4.07B | 3.99B | 3.94B | 3.88B |
| Operating Income | 722.72M | 697.50M | 670.40M | 654.44M | 636.64M |
| Income Before Tax | 695.68M | 676.82M | 652.75M | 632.16M | 620.12M |
| Income Tax Expenses | 168.10M | 163.15M | -10.32M | -15.68M | -21.98M |
| Earnings from Continuing Operations | 527.58 | 513.67 | 663.06 | 647.84 | 642.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 527.58M | 513.67M | 663.06M | 647.84M | 642.10M |
| EBIT | 722.72M | 697.50M | 670.40M | 654.44M | 636.64M |
| EBITDA | 813.90M | 791.65M | 765.87M | 751.02M | 735.55M |
| EPS Basic | 2.98 | 2.88 | 3.68 | 3.59 | 3.54 |
| Normalized Basic EPS | 2.46 | 2.37 | 2.27 | 2.18 | 2.11 |
| EPS Diluted | 2.93 | 2.84 | 3.64 | 3.54 | 3.50 |
| Normalized Diluted EPS | 2.42 | 2.34 | 2.24 | 2.16 | 2.09 |
| Average Basic Shares Outstanding | 708.66M | 713.54M | 718.62M | 722.42M | 726.00M |
| Average Diluted Shares Outstanding | 718.25M | 721.75M | 725.92M | 730.01M | 734.92M |
| Dividend Per Share | 0.63 | 0.61 | 0.60 | 0.58 | 0.57 |
| Payout Ratio | 20.99% | 21.12% | 16.07% | 16.14% | 15.92% |